Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satheesh Chonat

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Journal of Clinical Immunology|August 11, 2021
Correction to: T Cell‑Epstein‑Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non‑Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLHOded Shamriz, Deepak Kumar, Jenny Shim, et al.
Blood Cells, Molecules & Diseases|September 27, 2016
Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosisOmar Niss, Satheesh Chonat, Neha Dagaonkar, et al.
Transfusion|March 11, 2018
Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failureCheryl L Maier, Phillip J Gross, Christina L Dean, et al.
Human Mutation|December 31, 2017
Alu element insertion in PKLR gene as a novel cause of pyruvate kinase deficiency in Middle Eastern patientsHarry Lesmana, Lisa Dyer, Xia Li, et al.
The Journal of Allergy and Clinical Immunology|July 30, 2023
Frequency of HLA-DR<sup>+</sup>CD38<sup>hi</sup> T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disordersThinh H Nguyen, Deepak Kumar, Chengyu Prince, et al.
Blood Advances|September 8, 2022
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in childrenMichelle Schoettler, Elizabeth Stenger, Kathleen Spencer, et al.
American Journal of Hematology|January 30, 2023
Factor H autoantibodies contribute to complement dysregulation in multisystem inflammatory syndrome in children (MIS-C)Patricia E Zerra, Jennifer Stowell, Hans Verkerke, et al.
American Journal of Hematology|July 30, 2025
Eculizumab is Associated With Increased Infection Rates and Infection Related Mortality in Children With Thrombotic Microangiopathy After HCTMichelle L Schoettler, Robert Lisac, Joel Ofori, et al.
Frontiers in Immunology|August 8, 2022
Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway ActivationAlexandra Gerogianni, Jordan D Dimitrov, Alessandra Zarantonello, et al.
American Journal of Hematology|August 22, 2024
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuriaAustin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Journal of Clinical Immunology|August 11, 2021
Correction to: T Cell‑Epstein‑Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non‑Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLHOded Shamriz, Deepak Kumar, Jenny Shim, et al.
Blood Cells, Molecules & Diseases|September 27, 2016
Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosisOmar Niss, Satheesh Chonat, Neha Dagaonkar, et al.
Transfusion|March 11, 2018
Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failureCheryl L Maier, Phillip J Gross, Christina L Dean, et al.
Human Mutation|December 31, 2017
Alu element insertion in PKLR gene as a novel cause of pyruvate kinase deficiency in Middle Eastern patientsHarry Lesmana, Lisa Dyer, Xia Li, et al.
The Journal of Allergy and Clinical Immunology|July 30, 2023
Frequency of HLA-DR<sup>+</sup>CD38<sup>hi</sup> T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disordersThinh H Nguyen, Deepak Kumar, Chengyu Prince, et al.
Blood Advances|September 8, 2022
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in childrenMichelle Schoettler, Elizabeth Stenger, Kathleen Spencer, et al.
American Journal of Hematology|January 30, 2023
Factor H autoantibodies contribute to complement dysregulation in multisystem inflammatory syndrome in children (MIS-C)Patricia E Zerra, Jennifer Stowell, Hans Verkerke, et al.
American Journal of Hematology|July 30, 2025
Eculizumab is Associated With Increased Infection Rates and Infection Related Mortality in Children With Thrombotic Microangiopathy After HCTMichelle L Schoettler, Robert Lisac, Joel Ofori, et al.
Frontiers in Immunology|August 8, 2022
Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway ActivationAlexandra Gerogianni, Jordan D Dimitrov, Alessandra Zarantonello, et al.
American Journal of Hematology|August 22, 2024
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuriaAustin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, et al.
Pageof 9